Medical packaging materials prices 10% higher costs to make generic drugs face price pressure
Sharp rise in global oil, energy and raw materials, medical packing materialprices began to rise from the end of last year, continued to show a rising trendsince 2008. Whether medical packaging production enterprises orpharmaceutical enterprises will be the full test of the rising of the medical package material prices. And compared to the drugs production enterprise, the generic drug manufacturers will be under more pressure.
Enterprises to respond to government support
Compared with the medicine material slowly rise, since the start of the year, the drug package prices suddenly greatly soared, and continues to rise in price, letboth the domestic medical packaging production enterprises or pharmaceuticalenterprises are obviously felt enormous cost pressure. Facing the pressure of cost, each enterprise is through external means to resolve, but many enterprisesare still in an awkward position.
It is understood, in many medical packaging materials, paper packaging, gelatincapsules, medicinal butyl rubber stopper and medicinal glass tube package material prices were rising trend. Market data show that, animal prices lead tomedical gelatin production costs soared, the price per ton rose 10000 yuan.
Due to the upstream raw materials prices rose rapidly, resulting in compliance,qualified enterprises mechanism medicinal hollow capsules production and marketing in a loss of status, the situation of rising prices is estimated at least10%. polymer materials especially. Emulsified rubber plug material as an example, the earliest market price of 20000 yuan / ton, now rose to nearly 50000 yuan / ton, is expected to continue to rise to 60000 yuan / ton. At the same time,because the soda ash, gas and other raw materials prices increase, also makes the medicinal glass prices continued to rise, the average price reached 20%.
The price of raw materials rose firstly affect the pharmaceutical packagingenterprises production cost. It is reported, infusion packaging material whole purchase cost ratio from last year to enhance the 10%. equally, the drugs production enterprise production costs have also been implicated. A Dongguaninfusion production enterprises responsible person said, &ldquo such cost pressures to rely solely on internal digestion difficult. &rdquo
It is understood, the provisions of the state for two years a price adjustment, such as the case of rising costs, enterprises may apply to the competent department ofprice to the price. However, the personage inside course of study thinks, at present the country down the &ldquo trend of drug price, the enterprise is very difficult to separate the application &rdquo. Many companies say, medicalpackage material prices trend will not reverse in the short term, the policy supportof hope the relevant departments of the state to introduce and implement the relevant supporting as soon as possible. &ldquo if the material continues to go up, can cause the industry reshuffle. &rdquo Shanghai pharmaceutical packagingsupervision of director of Institute of Ji Wei said.
Pressure reflects the enterprise innovation ability
According to the insiders, because of the new drug market prices generally higher,so this round of package material prices have little impact on the high-tech R & Denterprises a greater impact, will be mainly to state pricing medicine production enterprises and cheap medicine production enterprises. Such as packagingcosts account for the total cost of a larger proportion of the infusion products,packaging material cost increases more obvious influence on the profit. But for thenew drug or imported drug, due to higher product prices, compared with commondrugs, the number of low prices, high raw material prices have the ability.
An industry source said, in fact in any one industry will face price increasesupstream production material may. The generic drug companies face too much pressure on the root cause lies in the lack of innovative capacity, generic productsovercapacity, it also exposed the shortcomings of the current most domesticenterprises simply rely on price competition to seek survival.
